Category: Research
ADHD Life Expectancy: Startling Findings and Urgent Action Required
Attention-deficit/hyperactivity disorder (ADHD) is often thought of as a childhood condition, but for many, it persists into adulthood, bringing with it a host of challenges. A groundbreaking new study has revealed a startling reality surrounding life expectancy. Adults diagnosed with ADHD in the UK are living significantly shorter lives than their peers. The research, published…
What Works for Adult ADHD: A Comprehensive Look at Treatments
Adult ADHD is a persistent neurodevelopmental condition affecting approximately 2.5% of the global adult population. Characterized by inattention, hyperactivity, and impulsivity, it often co-occurs with mood disorders, anxiety, and executive dysfunction, significantly impairing quality of life. While medications remain the cornerstone of treatment, non-pharmacological options are gaining attention due to safety concerns and patient preferences.…
Breaking Down Gender Bias in ADHD Assessment and Diagnosis
Introduction Attention Deficit Hyperactivity Disorder (ADHD) is widely recognized as a neurodevelopmental disorder, but its diagnosis and treatment have been historically gendered. The issue of gender bias in ADHD means that women are often underdiagnosed or misdiagnosed. While the gender gap in ADHD diagnosis has reduced over the years, women still face significant barriers in…
ADHD Diagnosis: Advancements in Objective Eye-Tracking Technology
IntroductionAttention-Deficit/Hyperactivity Disorder (ADHD) affects millions of school-aged children globally, with challenges in diagnosis often leading to delayed interventions. Traditional methods rely heavily on subjective assessments, risking both overdiagnosis and missed cases. Therefore, recent advancements in eye-tracking technology present an innovative, objective approach to ADHD diagnosis, offering insights into neuropsychological behavior patterns. Focus Keyword: Tags: ADHD,…
The Role of Sex Differences in Decision-Making Behavior in Adults with ADHD
Attention-Deficit/Hyperactivity Disorder (ADHD) has long been recognized as a neurodevelopmental condition impacting individuals across their lifespan. While traditionally thought of as a childhood disorder, approximately 3% of adults globally continue to live with ADHD symptoms into adulthood. Recent studies have shifted the focus towards understanding the nuanced gender differences in ADHD, particularly regarding decision-making behaviors…
How Gender and Intelligence Influence ADHD Detection Age
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that significantly affects children’s social, academic, and emotional development. While the condition is commonly diagnosed in boys, recent research has shed light on critical disparities in the age of diagnosis, influenced by sex, cognitive abilities, intelligence, and socioeconomic factors Key Findings on ADHD Diagnosis Delays Implications for Diagnosis…
ADHD Medication Could Be a Lifesaver, New Study Suggests
In a significant observational study conducted in Sweden, researchers have uncovered a potentially life-saving benefit of attention-deficit/hyperactivity disorder (ADHD) medication. The study, involving 148,578 individuals diagnosed with ADHD, reveals that the initiation of ADHD medication is associated with a reduced risk of death, especially from unnatural causes such as accidents and suicides. This comprehensive analysis,…
Vitamin D Supplementation and Its Effectiveness in ASD
Newly published paper explores the association between vitamin D levels and autism spectrum disorder (ASD), potential mechanisms of vitamin D’s involvement in ASD, and the effect of its supplementation on ASD symptoms. It highlights the impact of deficiency during pregnancy and early childhood on the development of ASD. Furthermore, the research paper delves into the…
New ADHD Treatments Herald Comorbid Anxiety & Depression
In the realm of Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, four promising pipeline agents are currently under late-stage development across the seven major markets (7MM), including the United States, Japan, Germany, the United Kingdom, France, Italy, and Spain. These agents are Otsuka’s Centanafadine SR, Axsome Therapeutics’s Solriamfetol, Neurocentria’s NRCT-101SR (L-Threonate magnesium salt), and Cingulate’s CTx-1301 (dexmethylphenidate). Notably,…
New Findings Emphasize Preterm Birth, DNA & Attention Problems
Latest study tells us, how DNA methylation in premature babies may be linked to attention problems later in childhood! The researchers looked at 441 premature babies. Researchers identified DNA methylation at 33 specific sites, associated with attention problems at age 2. This study is significant because it suggests that DNA methylation at birth could potentially…
